Bibliography for: "Prospects are bright as consumers return to basics"

"Prospects are bright as consumers return to basics". Chain Drug Review. FindArticles.com. 05 Jan, 2010. http://findarticles.com/p/articles/mi_hb3007/is_3_31/ai_n31352550/

Chain Drug Review

View more issues:

Articles in Feb 2, 2009 issue of Chain Drug Review

• Power brush sales whirring as prices drop
• New dentifrice may be sign of things to come
• Walgreens pursues transformation with sense of urgency
  by Richard Monks
• Health care on Obama agenda
• Plan for employers unveiled by Walgreens
• McKesson Canada aims to buy Uniprix
• Wal-Mart keeps pricing pressure on
• Kleiman becomes a VP at NACDS
• Rite Aid plans to close DC in New York state
• Duane Reade to settle suits
• NACDS, NCPA comment on health care tech measure
• In light of recession, CVS is careful with projections
• Integration of Longs on track
• Store openings will remain on even keel
• Pfizer plans big cuts in ranks of scientific, sales staffs
• B&L taps Valenti to head division
• 'Green living' touted by Nature's Bounty
• Wet n wild marks 30th anniversary with product intros
• Outlook for fiscal '09 reduced
• As CVS rose to top, Bodine was always there
  by David Pinto
• Innovation drives Alberto Culver
• Continental Consumer builds loyalty
• Prospects are bright as consumers return to basics
• Drug chains challenge supermarkets on their own turf
• Shoppers change ways amid rising prices
• Focus on nutrition sharpens
• Funky Monkey gets expanded distribution
• 'Skinny' frozen dessert launch
• Herbal sweetener sparks beverage battle
• More foods, drinks sport 'natural' moniker
• No sales crunch in salty snacks
• Survey: many adults can't resist urge to munch
• Retailers put muscle behind store brands
• Suppliers stress health benefits of good oral hygiene
• Toothbrush sanitizers carve niche
• Needs of children get renewed focus
• Can't miss with toothpaste
• ADA: time to change that brush
• Natural products show they can do the job
• Obesity trends
• Chronic illnesses
• Web calls
• Jeffrey Ives
• Sutro Biopharma
• Howard Feldman
• Horizon Therapeutics
• Les Paul
• Endo buys Indevus for $370 million
• Alzheimer's raises issues in clinical research
• An alternative to standard HRT gains momentum
• Orphan drug approved
• First brands
• Savella approved
• Astepro available
• Naprelan extension
• AllerNaze gets O.K
• NeoBenz debut
• Schering adds liqui-gel form to its Claritin allergy line
• Alli promotion
• Advil campaign
• Natural cold relief
• ClearEars unveiled
• Teva, Codexis sign pact
• Akorn-strides wins O.K
• Value of generics more apparent than ever
• A big factor in limiting Rx spending
• Top 150 generics by manufacturer and NDC11 number
• Multisource brands round out picture
• Top 150 multisource brands by manufacturer and NDC11 number
• Obama, Congress expected to increase access
• GPhA endorses CBO report on biopharmaceuticals
• Daschle's HHS appointment seen as boost for generics sector
• Lawmakers to reexamine marketing of authorized generics
• Founding dean appointed
• Aurora assists school
• CE catalog highlights
• Managing pain part of Rx role
  by John Dwyer
• NABP test computerized
• Congress combats economic woes
• Investment in Rite Aid pushes Jean Coutu into the red

• 1
• 2